European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Herbal medicinal product: Fragariae folium, Fragaria vesca L., Fragaria moschata Weston,Fragaria viridis Weston,Fragaria x ananassa (Weston) Duchesne ex Rozier , F: Assessment finalised

Submitted by Anonymous (not verified) on 3 September 2026 - 14:45

Herbal medicinal product: Fragariae folium, Fragaria vesca L., Fragaria moschata Weston,Fragaria viridis Weston,Fragaria x ananassa (Weston) Duchesne ex Rozier , F: Assessment finalised

Human medicines European public assessment report (EPAR): Pomalidomide Krka, pomalidomide, Date of authorisation: 24/07/2024, Revision: 3, Status: Authorised

Submitted by Anonymous (not verified) on 3 September 2026 - 14:32

Human medicines European public assessment report (EPAR): Pomalidomide Krka, pomalidomide, Date of authorisation: 24/07/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Velsipity, etrasimod, Date of authorisation: 16/02/2024, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 3 September 2026 - 14:30

Human medicines European public assessment report (EPAR): Velsipity, etrasimod, Date of authorisation: 16/02/2024, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil, Date of authorisation: 16/12/2016, Revision: 19, Status: Authorised

Submitted by Anonymous (not verified) on 3 September 2026 - 13:30

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil, Date of authorisation: 16/12/2016, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Ambrisentan Viatris (previously Ambrisentan Mylan), ambrisentan, Date of authorisation: 20/06/2019, Revision: 10, Status: Authorised

Submitted by Anonymous (not verified) on 3 September 2026 - 13:22

Human medicines European public assessment report (EPAR): Ambrisentan Viatris (previously Ambrisentan Mylan), ambrisentan, Date of authorisation: 20/06/2019, Revision: 10, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More